liquid biopsy holds a promising approach for the early detection of cancer: Current information and future perspectives.

Autor: Shbeer AM; Department of Surgery, Faculty of Medicine, Jazan University, Jazan, Saudi Arabia. Electronic address: ashbeer@jazanu.edu.sa., Robadi IA; Department of Pathology, Faculty of Medicine, Jazan University, Jazan, Saudi Arabia. Electronic address: Irobaidi@jazanu.edu.sa.
Jazyk: angličtina
Zdroj: Pathology, research and practice [Pathol Res Pract] 2024 Feb; Vol. 254, pp. 155082. Date of Electronic Publication: 2024 Jan 03.
DOI: 10.1016/j.prp.2023.155082
Abstrakt: Cancer is becoming a global pandemic, and its occurrence is increasing rapidly, putting a strain on people's families, health systems, and finances, in addition to their physical, mental, and emotional well-being. Many cancer types lack screening programs, and many people at high risk of developing cancer do not follow recommended medical screening regimens because of the nature of currently available screening tests and other compliance issues, despite cancer being the second leading cause of death worldwide. Furthermore, a lot of liquid biopsy methods for early cancer screening are not sensitive enough to catch cancer early. Cancer treatment costs increase with the time it takes to diagnose the disease; therefore, early detection is essential to enhance the quality of life and survival rates. The current status of the liquid biopsy sector is examined in this paper.
Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2024 Elsevier GmbH. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: